These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25737401)

  • 1. Dry eye specific quality of life in veterans using glaucoma drops.
    Camp A; Wellik SR; Tzu JH; Feuer W; Arheart KL; Sastry A; Galor A
    Cont Lens Anterior Eye; 2015 Jun; 38(3):220-5. PubMed ID: 25737401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of ocular surface symptoms on quality of life in a United States veterans affairs population.
    Pouyeh B; Viteri E; Feuer W; Lee DJ; Florez H; Fabian JA; Perez VL; Galor A
    Am J Ophthalmol; 2012 Jun; 153(6):1061-66.e3. PubMed ID: 22330309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to Glaucoma Medication Compliance Among Veterans: Dry Eye Symptoms and Anxiety Disorders.
    Stringham J; Ashkenazy N; Galor A; Wellik SR
    Eye Contact Lens; 2018 Jan; 44(1):50-54. PubMed ID: 28181960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of glaucoma medications and ocular surface disease on the quality of life of glaucoma patients in the district of Sousse (Tunisia)].
    Leila K; Gatfaoui F; Mahjoub A; Yakoubi S; Krifa F; Ghorbel M; Mahjoub H
    J Fr Ophtalmol; 2019 May; 42(5):464-470. PubMed ID: 30928241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dry Eye Symptoms and Ocular Pain in Veterans with Glaucoma.
    Tirpack AR; Vanner E; Parrish JM; Galor A; Hua HU; Wellik SR
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31336584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dry eye syndrome-related quality of life in glaucoma patients.
    Rossi GC; Tinelli C; Pasinetti GM; Milano G; Bianchi PE
    Eur J Ophthalmol; 2009; 19(4):572-9. PubMed ID: 19551671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Readability of prescription labels and medication recall in a population of tertiary referral glaucoma patients.
    O'Hare F; Jeganathan VS; Rokahr CG; Rogers SL; Crowston JG
    Clin Exp Ophthalmol; 2009 Dec; 37(9):849-54. PubMed ID: 20092593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ocular surface in glaucoma patients with topical treatment].
    Zemba M; Papadatu CA; Enache VE; Sârbu LN
    Oftalmologia; 2011; 55(3):94-8. PubMed ID: 22428298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients.
    Guarnieri A; Carnero E; Bleau AM; Alfonso-Bartolozzi B; Moreno-Montañés J
    Int Ophthalmol; 2020 Mar; 40(3):741-751. PubMed ID: 31813109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical audit examining the impact of benzalkonium chloride-free anti-glaucoma medications on patients with symptoms of ocular surface disease.
    Goldberg I; Graham SL; Crowston JG; d'Mellow G;
    Clin Exp Ophthalmol; 2015 Apr; 43(3):214-20. PubMed ID: 25196488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dry eye symptoms align more closely to non-ocular conditions than to tear film parameters.
    Galor A; Felix ER; Feuer W; Shalabi N; Martin ER; Margolis TP; Sarantopoulos CD; Levitt RC
    Br J Ophthalmol; 2015 Aug; 99(8):1126-9. PubMed ID: 25710726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glaucoma and dry eye. Current concepts and future perspectives].
    Steven P; Cursiefen C
    Ophthalmologe; 2013 Dec; 110(12):1155-9. PubMed ID: 24129917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dry eye syndrome, posttraumatic stress disorder, and depression in an older male veteran population.
    Fernandez CA; Galor A; Arheart KL; Musselman DL; Venincasa VD; Florez HJ; Lee DJ
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3666-72. PubMed ID: 23633658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma.
    Rees G; Leong O; Crowston JG; Lamoureux EL
    Ophthalmology; 2010 May; 117(5):903-8. PubMed ID: 20153902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of quality of life measures in dry eye questionnaires.
    Grubbs JR; Tolleson-Rinehart S; Huynh K; Davis RM
    Cornea; 2014 Feb; 33(2):215-8. PubMed ID: 24326332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of ocular surface disease in glaucoma patients.
    Leung EW; Medeiros FA; Weinreb RN
    J Glaucoma; 2008 Aug; 17(5):350-5. PubMed ID: 18703943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tear film osmolarity in patients treated for glaucoma or ocular hypertension.
    Labbé A; Terry O; Brasnu E; Van Went C; Baudouin C
    Cornea; 2012 Sep; 31(9):994-9. PubMed ID: 22710490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dry eye symptom severity and persistence are associated with symptoms of neuropathic pain.
    Galor A; Zlotcavitch L; Walter SD; Felix ER; Feuer W; Martin ER; Margolis TP; Sarantopoulos KD; Levitt RC
    Br J Ophthalmol; 2015 May; 99(5):665-8. PubMed ID: 25336572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications.
    Fechtner RD; Godfrey DG; Budenz D; Stewart JA; Stewart WC; Jasek MC
    Cornea; 2010 Jun; 29(6):618-21. PubMed ID: 20386433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of initial topical medical therapy on short-term quality of life in newly diagnosed patients with primary glaucoma.
    Arora V; Bali SJ; Gupta SK; Vashisht P; Agarwal T; Sreenivas V; Dada T
    Indian J Ophthalmol; 2015 Jun; 63(6):511-5. PubMed ID: 26265642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.